dihydrocodeine and 2019 Novel Coronavirus Disease

dihydrocodeine has been researched along with 2019 Novel Coronavirus Disease in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's1 (100.00)2.80

Authors

AuthorsStudies
Acosta-Mena, D; Adderley, NJ; Anand, A; Bhala, N; Buckley, CD; Byne, N; Chandan, JS; Cooper, J; Denniston, AK; Dhalla, S; Gokhale, KM; Haroon, S; Lord, J; Nirantharakumar, K; Okoth, KO; Raza, K; Sainsbury, C; Subramanian, A; Taverner, T; Thayakaran, R; Thomas, GN; Thomas, T; Wang, J; Zemedikun, DT1

Other Studies

1 other study(ies) available for dihydrocodeine and 2019 Novel Coronavirus Disease

ArticleYear
Nonsteroidal Antiinflammatory Drugs and Susceptibility to COVID-19.
    Arthritis & rheumatology (Hoboken, N.J.), 2021, Volume: 73, Issue:5

    Topics: Acetaminophen; Adult; Aged; Aged, 80 and over; Analgesics; Anti-Inflammatory Agents, Non-Steroidal; Case-Control Studies; Cause of Death; Codeine; COVID-19; Disease Susceptibility; Drug Combinations; Female; Humans; Incidence; Male; Middle Aged; Mortality; Osteoarthritis; Primary Health Care; Propensity Score; Proportional Hazards Models; Risk Factors; SARS-CoV-2; United Kingdom

2021